ALB and type 2 diabetes mellitus: We have demonstrated in T2DM patients that plasma NEFA levels are sufficiently elevated such as to alter plasma zinc speciation and have shown the impact of additional non-HSA bound Zn2+ binding to coagulation proteins on clot processes.